Prescription ID | TCMF4148 |
Pinyin Name | Jin Sha Wu Lin Wan |
Chinese Name | 金砂五淋丸 |
English Name | Jin Sha Wu Lin Pills |
Function Description | 热淋 |
Indications | Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
Disease ICD-11 Category |
SA91 [Heat stranguria disorder (TM1), 热淋 (TM1)
]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的前列腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性前列腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾小管-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿道炎和尿道综合征 ]; |
Human Tissues Associated with Indication | Bladder |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH780 | Lygodium japonicum | 海金砂 | TCMH780 | ITSAJ4232-14 |
TCMH2671 | Polyporus umbellatus | 猪苓 | TCMH2671 | NOBAS3307-16 |
TCMH1706 | Dianthus superbus | 瞿麦 | TCMH1706 | ITSAJ4556-14 |
TCMH363 | Rheum officinale | 大黄 | TCMH363 | ITSAJ4685-14 |
TCMH258 | Paeonia obovata | 赤芍 | TCMH258 | GBVX7902-15 |
TCMH177 | Polygonum aviculare | 萹蓄 | TCMH177 | ITSAG3700-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH718 | Aristolochia manshuriensis | 关木通 | TCMH718 | GBVE2055-11 |
TCMH949 | Phellodendron amurense | 黄柏 | TCMH949 | ITSAM1586-14 |
TCMH451 | Rehmannia glutinosa | 地黄 | TCMH451 | ITSAH4578-14 |
TCMH241 | Plantago asiatica | 车前子 | TCMH241 | ITSAB3641-14 |
TCMH986 | Scutellaria baicalensis | 黄芩 | TCMH986 | ITSAP4211-14 |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT151 | PRKCA | Protein kinase C alpha | Kinase | P17252 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT160 | HTR7 | Serotonin 7 (5-HT7) receptor | GPCR | P34969 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT22 | ALPI | Intestinal alkaline phosphatase | Hydrolase | P09923 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT283 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Hydrolase | Q13332 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT313 | HTR2B | Serotonin 2b (5-HT2b) receptor | GPCR | P41595 |
TCMT314 | HTR2C | Serotonin 2c (5-HT2c) receptor | GPCR | P28335 |
TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT36 | HTR1A | Serotonin 1a (5-HT1a) receptor | GPCR | P08908 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT37 | HTR2A | Serotonin 2a (5-HT2a) receptor | GPCR | P28223 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT645 | HTR1E | Serotonin 1e (5-HT1e) receptor | GPCR | P28566 |
TCMT646 | HTR5A | Serotonin 5a (5-HT5a) receptor | GPCR | P47898 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT801 | TUBB3 | Tubulin beta-3 chain | Unclassified | Q13509 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT815 | HTR1D | Serotonin 1d (5-HT1d) receptor | GPCR | P28221 |
TCMT816 | HTR1B | Serotonin 1b (5-HT1b) receptor | GPCR | P28222 |
TCMT817 | HTR4 | Serotonin 4 (5-HT4) receptor | GPCR | Q13639 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1182 | Streptococcus sanguinis |
TCMT1183 | Candida albicans SC5314 |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1191 | Bacillus megaterium |
TCMT1198 | Serratia marcescens |
TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1230 | Human herpesvirus 5 |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1305 | Salmonella enteritidis |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1319 | Corynebacterium xerosis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1385 | Candida shehatae |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1460 | Mycobacterium intracellulare |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS1, PTGS2, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 15.9642 |
[BP] GO:0007210 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8678 |
[BP] GO:0098664 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8678 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 13.8039 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 13.7755 |
[BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PPARA, PRKCA, PTGS2, RORC, SMAD3, SRC, TEK, TYR | 12.5176 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 11.9593 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, FABP3, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TEK, TYR | 11.2778 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR5A, IGF1R, INSR, KDR, MMP2, PIK3CA, PPARA, PRKCA, PTGS2, RORC, SMAD3, SRC, TEK, TYR | 11.226 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 11.166 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.0028 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 11.0028 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 11.0028 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 10.9685 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.1694 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 9.58902 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, GLO1, HSPA1A, HTR2B, HTR2C, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH | 9.56716 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TNKS2, TYR | 9.55515 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, PRKCA | 9.5363 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH | 9.50174 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SRC, TEK, TYR | 9.45866 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, EGFR, ESR1, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH | 9.44424 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH | 9.41819 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CNR1, DRD1, DRD2, EGFR, HCAR2, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 | 9.11061 |
[BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APEX1, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK | 9.03943 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 8.9096 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH | 8.9096 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 8.88261 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 8.86686 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA6, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR | 8.75775 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, PTGS2, RORC, SRC, TYR | 8.69553 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 | 8.65643 |
[BP] GO:0007187 | None | ADORA1, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 | 8.64352 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, APEX1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, PTGS2, SRC | 8.58619 |
[BP] GO:0097756 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 8.30444 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 8.30444 |
[BP] GO:0003018 | None | ADORA1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK | 8.29939 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, PTPRS, SRC, TEK, TNKS, XDH | 8.19515 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 7.99381 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 7.99381 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TEK | 7.93648 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 | 7.85121 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, INSR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 7.85121 |
[BP] GO:0048583 | regulation of response to stimulus | ABCB1, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP4, FLT3, GPR35, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 7.83031 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, INSR, PPARA, PTGS2, SRC, TEK | 7.77977 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, PTPRS, SRC, TEK, TNKS, XDH | 7.71314 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 | 7.57814 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 7.54404 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 7.46782 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 7.44668 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK | 7.38565 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, CNR1, CNR2, DRD2, HTR1B | 7.34479 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK | 7.34479 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.19089 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, HTR1D, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 7.1551 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 7.11437 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 7.1114 |
[BP] GO:0003013 | None | ADORA1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK | 7.03394 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 6.99295 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, CNR1, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 | 6.96497 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TNKS2, TOP2A, TYR | 6.96497 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 6.96497 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 6.96497 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH | 6.9278 |
[BP] GO:0097746 | None | ADORA1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 6.9278 |
[BP] GO:0035296 | None | ADORA1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 6.9278 |
[BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, EGFR, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC | 6.9278 |
[BP] GO:0007198 | None | HTR1A, HTR1B, HTR5A, HTR7 | 6.91368 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK | 6.74935 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGS2, SRC | 6.73404 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 | 6.72707 |
[BP] GO:0050795 | None | ADORA1, CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B | 6.72707 |
[BP] GO:0050880 | None | ADORA1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 6.69552 |
[BP] GO:0035150 | None | ADORA1, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 6.66744 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D, KDR, SRC | 6.64892 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, CNR1, DRD1, DRD2, EGFR, HCAR2, PIK3CB, PTGS2, TNKS, TNKS2 | 6.64556 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.6354 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC | 6.62868 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 | 6.54112 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC, TEK | 6.53216 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.47303 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 6.46698 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, INSR, PIK3CA, PIK3CB, SRC | 6.42873 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, RORC, SRC, TEK | 6.30102 |
[BP] GO:0007193 | None | ADORA1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 6.18431 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, PIK3CB, PRKCA, PTPN1, SRC, TEK, XDH | 6.18375 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK | 6.16603 |
[BP] GO:0030335 | positive regulation of cell migration | BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 6.14899 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, CNR1, CNR2, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR | 6.10244 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 | 6.09769 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3 | 6.07986 |
[BP] GO:0007188 | None | ADORA1, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 6.07969 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 6.07378 |
[BP] GO:0042310 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 | 6.06419 |
[BP] GO:0080134 | regulation of response to stress | ABCB1, ADORA1, CNR1, CNR2, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PRKCA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, XDH | 6.04449 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 6.04255 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC | 6.00755 |
[BP] GO:2000147 | positive regulation of cell motility | BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 5.98754 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, PRKCA, PTGS2, PTPRS, SMAD3, TEK | 5.93882 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR1B, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SMAD3, SRC | 5.92629 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 5.90682 |
[BP] GO:0051272 | positive regulation of cellular component movement | BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 5.83972 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, SRC, TEK | 5.83972 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 5.82458 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, DRD2, DUSP3, EGFR, HTR2A, HTR2B, HTR2C, KDR, PRKCA, PTPN1, SRC, TEK | 5.82224 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 5.7837 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.77959 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, DRD2, DUSP3, EGFR, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, PIK3CB, PRKCA, PTPN1, SRC, TEK, XDH | 5.76997 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR | 5.68664 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP3, FABP4, GLO1, GPR35, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 5.6635 |
[BP] GO:0040017 | positive regulation of locomotion | BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PTGS2, SMAD3, SRC, TEK | 5.65855 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, CNR1, CNR2, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR | 5.64691 |
[BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA | 5.62887 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HTR1B, IGF1R, INSR, KDR, MMP2, PIK3CA, PTGS2, RORC, SMAD3, SRC | 5.62125 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.56422 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC, TEK | 5.54704 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PTGS1, PTGS2 | 5.49001 |
[BP] GO:0006468 | protein phosphorylation | AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, SRC, TEK, TNKS | 5.48997 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 | 5.41787 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 | 5.41787 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2 | 5.39258 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, BCL2, CNR1, DRD2, GPR35, HTR1B, HTR2A, MMP9, PTGS2 | 5.37986 |
[BP] GO:0032845 | None | ADORA1, BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC, TNKS, TNKS2 | 5.30304 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 5.24153 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.23974 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, DUSP3, EGFR, ESR1, GPR35, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SMAD3, SRC, XDH | 5.23275 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, PRKCA, SRC, TEK | 5.22838 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK | 5.21644 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, DUSP3, EGFR, ESR1, GPR35, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SMAD3, SRC, XDH | 5.2157 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.20577 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 5.20323 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, PPARA, PTPRS, SMAD3, SRC, TEK, TYR | 5.18515 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 5.18092 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 5.13993 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.13657 |
[BP] GO:0065009 | regulation of molecular function | ABCB1, ADORA1, ADORA3, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 5.12098 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.11937 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC, TEK | 5.11937 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 5.10603 |
[BP] GO:0071073 | None | FABP3, HTR2A, HTR2B, HTR2C | 5.09273 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 5.02256 |
[BP] GO:0009894 | regulation of catabolic process | ADORA1, APEX1, BCL2, CNR1, CSNK2A1, EGFR, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PTPN1, SMAD3 | 4.9909 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, NQO2, PTGS1, RORC | 4.97439 |
[BP] GO:0006939 | None | DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 | 4.84051 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DRD2, EGFR, ESR1, HTR7, PPARA, RORC, SRC, TOP2A | 4.76576 |
[BP] GO:0016310 | phosphorylation | AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TNKS | 4.76453 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, XDH | 4.76137 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GLO1, HSPA1A, HTR1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 4.72418 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SMAD3, SRC, TEK | 4.70615 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SRC, TNKS | 4.68837 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 4.67529 |
[BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 4.67464 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ESR1, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 4.62065 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 4.59766 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 | 4.57742 |
[BP] GO:0099536 | None | CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 4.57046 |
[BP] GO:0099537 | None | CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 4.57046 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TEK, XDH | 4.45373 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 4.45373 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.44908 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.39458 |
[BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 4.38514 |
[BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA | 4.35229 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 4.33505 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 4.3303 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.3303 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR1B, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, PTPN1, RORC, SMAD3, SRC, TOP2A | 4.27287 |
[BP] GO:0051967 | None | ADORA1, DRD2, HTR1B, HTR2A | 4.27287 |
[BP] GO:0016477 | cell migration | AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK | 4.21389 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PPARA, PTGS1, PTGS2 | 4.20464 |
[BP] GO:0009895 | negative regulation of catabolic process | ADORA1, BCL2, CNR1, EGFR, HCAR2, HTR2B, MET, PIK3CA, PPARA, SMAD3 | 4.17901 |
[BP] GO:0046883 | regulation of hormone secretion | ADORA1, CNR1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR2A, HTR2C, PRKCA | 4.17901 |
[BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, SRC, TEK, TYR | 4.17363 |
[BP] GO:0008217 | None | ADORA1, CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 | 4.15743 |
[BP] GO:0021885 | forebrain cell migration | AXL, DRD1, DRD2, EGFR, HTR6 | 4.14068 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, INSR, PIK3CA, PTGS2, SRC, TEK, TYR | 4.13172 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1A, HTR2C, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A | 4.07785 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HTR1A, TYR | 4.07514 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, PIK3CB, PTPN1, SRC | 4.0706 |
[BP] GO:0050801 | ion homeostasis | BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 4.06384 |
[BP] GO:0071071 | None | FABP3, HTR2A, HTR2B, HTR2C | 4.04566 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC | 4.04268 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC | 4.04076 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC | 4.01616 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC | 3.98534 |
[BP] GO:0010513 | None | HTR2A, HTR2B, HTR2C | 3.97641 |
[BP] GO:1903530 | regulation of secretion by cell | ACHE, ADORA1, CNR1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, PRKCA, SRC | 3.97279 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, PRKCA, SRC, TEK, TNKS, TOP2A | 3.95459 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC | 3.95459 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK, TNKS | 3.95459 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, HTR1B, KDR, PTGS2, SRC | 3.9398 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC | 3.92669 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK | 3.87751 |
[BP] GO:0014821 | None | DRD1, DRD2, HTR1D, HTR2B | 3.85061 |
[BP] GO:0043269 | regulation of ion transport | ABCB1, ADORA1, BCL2, CA2, CA7, CNR1, DRD1, DRD2, GPR35, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 | 3.84869 |
[BP] GO:0007268 | None | DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.81769 |
[BP] GO:0098916 | None | DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.81769 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, HSPA1A | 3.79272 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA | 3.78729 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APEX1, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD2, DUSP3, EGFR, ESR1, FABP4, HCAR2, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH | 3.77122 |
[BP] GO:0090066 | None | ADORA1, ALOX15, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.77122 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK, TNKS | 3.77122 |
[BP] GO:0051952 | None | ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A | 3.77122 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2 | 3.77122 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CNR2, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK | 3.76778 |
[BP] GO:0048870 | cell motility | AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK | 3.72947 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 | 3.72947 |
[BP] GO:0040011 | locomotion | AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK | 3.7239 |
[BP] GO:0032229 | None | ADORA1, CNR2, HTR1B | 3.72233 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC | 3.72098 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, HTR5A, INSR, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TYR | 3.72098 |
[BP] GO:0018958 | None | AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR | 3.71797 |
[BP] GO:0007610 | None | BCL2, CNR1, DRD1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, PPARA, PTGS2 | 3.7122 |
[BP] GO:0044093 | positive regulation of molecular function | ABCB1, ADORA1, AURKB, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 3.65315 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, PTGS2, SRC, TEK | 3.64818 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 3.64702 |
[BP] GO:0051046 | None | ACHE, ADORA1, CNR1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, PRKCA, SRC | 3.63643 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.62992 |
[BP] GO:0098771 | inorganic ion homeostasis | BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.61571 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, SMAD3, TEK | 3.59097 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 3.57785 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 3.57364 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESR1, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH | 3.54573 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 3.53852 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, AURKB, AXL, BCL2, CNR1, DRD2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.53852 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, DUSP3, ESR1, HCAR2, HSPA1A, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PTPN1, PTPRS, SMAD3, SRC | 3.52596 |
[BP] GO:0010038 | response to metal ion | ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGS2 | 3.52596 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC | 3.51738 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.51738 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.51738 |
[BP] GO:0010511 | None | HTR2A, HTR2B, HTR2C | 3.51738 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, F3, HCAR2, HSPA1A, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, PRKCA, PTGS2, SMAD3, SRC, TEK | 3.50825 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APEX1, AURKB, BCL2, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, TNKS, TOP2A | 3.50825 |
[BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, HCAR2, HTR2B, INSR, MMP12, PTGS2, SMAD3, SRC | 3.49146 |
[BP] GO:0007200 | None | DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C | 3.47895 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, AURKB, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 3.47544 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, EGFR, HTR1A, INSR, PTGS2, SMAD3 | 3.46234 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB | 3.45409 |
[BP] GO:0007154 | None | ADORA1, AXL, BCL2, CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2, TEK | 3.43451 |
[BP] GO:2001023 | None | CNR1, DRD1, DRD2, HTR1B, HTR2A, MET | 3.42882 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.42037 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.40161 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CB, PTPN1, SRC | 3.35062 |
[BP] GO:0072507 | divalent inorganic cation homeostasis | BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.32404 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 3.3214 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 3.30058 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 3.29633 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC | 3.27876 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 3.23743 |
[BP] GO:1901652 | response to peptide | AKR1B1, APEX1, FABP3, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK | 3.22463 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 3.22463 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DRD2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 3.21623 |
[BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, CNR2, CYP19A1, DRD1, DRD2, PPARA, PTPRS, SMAD3, TEK | 3.18019 |
[BP] GO:0032103 | positive regulation of response to external stimulus | CNR1, EGFR, F3, FABP4, KDR, MET, PRKCA, PTGS2, SMAD3 | 3.18019 |
[BP] GO:0090087 | None | ACHE, ADORA1, CA2, CNR1, DRD2, EGFR, HCAR2, HTR2B, HTR2C, MMP12, PRKCA, PTGS2, PTPN1, SMAD3, SRC | 3.17028 |
[BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.16935 |
[BP] GO:0014059 | None | CNR1, DRD2, HTR1B, HTR2A | 3.15297 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.14877 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.14877 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.14877 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.14877 |
[BP] GO:0006928 | movement of cell or subcellular component | AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, TEK, TUBB3 | 3.13291 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.12937 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, KDR, PIK3CB, SMAD3, SRC, TEK | 3.10383 |
[BP] GO:0007267 | None | ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, TEK | 3.1011 |
[BP] GO:0055080 | cation homeostasis | BCL2, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.08775 |
[BP] GO:0048015 | phosphatidylinositol-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.08644 |
[BP] GO:0007613 | None | CNR1, DRD1, DRD2, HTR2A, INSR, PTGS2 | 3.06253 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 3.05418 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.05418 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC, TEK | 3.05418 |
[BP] GO:0002791 | None | ACHE, ADORA1, CNR1, DRD2, EGFR, HCAR2, HTR2B, HTR2C, MMP12, PRKCA, SRC | 3.05355 |
[BP] GO:0002209 | None | BCL2, DRD1, HTR1A, HTR2C | 3.05355 |
[BP] GO:0001662 | None | BCL2, DRD1, HTR1A, HTR2C | 3.05355 |
[BP] GO:0051726 | regulation of cell cycle | APEX1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, PTGS2, SMAD3, SRC, TNKS, TOP2A | 3.05239 |
[BP] GO:0045787 | positive regulation of cell cycle | APEX1, AURKB, CDC25B, CYP1A1, DRD2, DUSP3, EGFR, INSR, PRKCA, SRC | 3.034 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR | 3.02727 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.00543 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2, HTR2A | 3.00183 |
[BP] GO:0046889 | None | FABP3, HTR2A, HTR2B, HTR2C, PTGS2 | 3.00183 |
[BP] GO:0048017 | inositol lipid-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.00183 |
[BP] GO:0065007 | biological regulation | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 3.00036 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 2.95282 |
[BP] GO:0022029 | None | DRD1, DRD2, EGFR, HTR6 | 2.95282 |
[BP] GO:0042596 | None | BCL2, DRD1, HTR1A, HTR2C | 2.95282 |
[BP] GO:0006874 | cellular calcium ion homeostasis | BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.94722 |
[BP] GO:0002031 | None | DRD2, HTR1B, HTR2B | 2.9394 |
[BP] GO:0019371 | None | CBR1, PTGS1, PTGS2 | 2.9394 |
[BP] GO:0055082 | cellular chemical homeostasis | BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, SMAD3 | 2.93861 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR | 2.92981 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH | 2.90752 |
[BP] GO:0010863 | positive regulation of phospholipase C activity | EGFR, ESR1, HTR2A, HTR2B | 2.90701 |
[BP] GO:1900542 | None | DRD1, DRD2, HTR1B, HTR1E, HTR2A, INSR, PPARA, PRKCA | 2.90663 |
[BP] GO:0030003 | cellular cation homeostasis | BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.87752 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CNR2, CYP19A1, PPARA, SMAD3, TEK | 2.87116 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 2.86436 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 2.85693 |
[BP] GO:0055074 | calcium ion homeostasis | BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.84665 |
[BP] GO:0030155 | regulation of cell adhesion | ALOX15, BCL2, CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, SMAD3, SRC, TEK | 2.84648 |
[BP] GO:0007208 | None | HTR2A, HTR2C | 2.84648 |
[BP] GO:0042738 | exogenous drug catabolic process | CYP1A2, CYP2A6, CYP3A4 | 2.83857 |
[BP] GO:0045759 | None | CNR1, CNR2, GPR35 | 2.83857 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APEX1, DRD1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, SRC | 2.83857 |
[BP] GO:0006140 | None | DRD1, DRD2, HTR1B, HTR1E, HTR2A, INSR, PPARA, PRKCA | 2.83282 |
[BP] GO:0050679 | None | EGFR, F3, HTR2B, KDR, MMP12, PRKCA, TEK | 2.83154 |
[BP] GO:0048732 | gland development | BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR | 2.8223 |
[BP] GO:1900543 | None | DRD2, HTR1B, HTR1E, PPARA, PRKCA | 2.81763 |
[BP] GO:0072503 | cellular divalent inorganic cation homeostasis | BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.81642 |
[BP] GO:0006873 | cellular ion homeostasis | BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.7962 |
[BP] GO:0045980 | None | DRD2, HTR1B, HTR1E, PPARA, PRKCA | 2.79268 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 2.79268 |
[BP] GO:1900274 | regulation of phospholipase C activity | EGFR, ESR1, HTR2A, HTR2B | 2.78219 |
[BP] GO:0031329 | regulation of cellular catabolic process | APEX1, BCL2, CNR1, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PTPN1 | 2.78198 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, HSD11B2, HSD17B2, INSR, MMP2, MMP9, PTGS2, SRC, TOP2A | 2.77468 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APEX1, DRD1, EGFR, ESR1, FLT3, HTR1B, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC | 2.77101 |
[BP] GO:0019725 | cellular homeostasis | APEX1, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, SMAD3 | 2.76723 |
[BP] GO:0002683 | negative regulation of immune system process | ADORA1, ALOX15, AXL, CNR1, CNR2, CYP19A1, DRD2, DUSP3, MMP12, PTPRS | 2.75331 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.74389 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX15, ALOX5, PTGS1, PTGS2 | 2.7421 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A | 2.73956 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR | 2.70361 |
[BP] GO:0050678 | None | EGFR, F3, HTR2B, KDR, MMP12, PRKCA, SMAD3, TEK, XDH | 2.69694 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, PIK3CB, PTPN1, SRC | 2.69352 |
[BP] GO:0023052 | None | ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, TEK | 2.68598 |
[BP] GO:0002793 | None | ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC | 2.68435 |
[BP] GO:0001525 | angiogenesis | CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2, TEK | 2.67341 |
[BP] GO:0038128 | None | EGFR, PIK3CA, PRKCA, SRC | 2.6623 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK | 2.66189 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.6567 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2 | 2.6567 |
[BP] GO:0006650 | glycerophospholipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB | 2.64818 |
[BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CNR1, CYP1B1, F3, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH | 2.63461 |
[BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CNR1, CYP1B1, F3, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH | 2.59453 |
[BP] GO:0003012 | None | ADORA1, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA | 2.58982 |
[BP] GO:0044057 | None | ADORA1, ADORA3, DRD2, EGFR, GPR35, HCAR2, HTR2A, HTR2C, PRKCA, PTGS2, SMAD3 | 2.58754 |
[BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, INSR, PTGS2, SMAD3 | 2.58754 |
[BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.58754 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APEX1, DRD1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, SRC | 2.58754 |
[BP] GO:0001936 | None | F3, HTR2B, KDR, PRKCA, TEK, XDH | 2.57418 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 2.57344 |
[BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, PTGS2, TYR | 2.55899 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR | 2.55899 |
[BP] GO:0009891 | positive regulation of biosynthetic process | AURKB, DRD1, DRD2, EGFR, ESR1, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A | 2.5548 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.5548 |
[BP] GO:0045776 | None | ADORA1, CNR1, DRD2, PPARA | 2.5548 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 | 2.53489 |
[BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CB, PTPN1, SRC | 2.51968 |
[BP] GO:0006811 | None | ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, HTR2A, HTR2B, HTR2C, PPARA | 2.5155 |
[BP] GO:0050890 | None | ADORA1, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, PTGS2 | 2.5155 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR | 2.51104 |
[BP] GO:2000811 | negative regulation of anoikis | BCL2, PIK3CA, SRC | 2.5018 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.5018 |
[BP] GO:0032225 | None | DRD1, DRD2, PTGS2 | 2.5018 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.5018 |
[BP] GO:0010595 | positive regulation of endothelial cell migration | KDR, MET, PRKCA, PTGS2, TEK | 2.4986 |
[BP] GO:0006464 | cellular protein modification process | ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.4971 |
[BP] GO:0036211 | protein modification process | ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.4971 |
[BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 | 2.49065 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APEX1, AURKB, BCL2, CNR1, CSNK2A1, DRD2, DUSP3, ESR1, FABP4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH | 2.49065 |
[BP] GO:0050999 | None | CNR1, CNR2, EGFR, HTR2B | 2.49065 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH | 2.48393 |
[BP] GO:0001938 | None | F3, HTR2B, KDR, PRKCA, TEK | 2.48233 |
[BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC | 2.47632 |
[BP] GO:0043434 | None | APEX1, FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK | 2.46637 |
[BP] GO:0051209 | None | DRD2, HTR2A, HTR2B, HTR2C | 2.45884 |
[BP] GO:0051283 | None | DRD2, HTR2A, HTR2B, HTR2C | 2.45884 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH | 2.45564 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.45564 |
[BP] GO:0033602 | None | CNR1, DRD2 | 2.45564 |
[BP] GO:0044267 | cellular protein metabolic process | ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIK3CA, PIM1, PRKCA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.45079 |
[BP] GO:0006082 | organic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR | 2.45034 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.44089 |
[BP] GO:0055065 | metal ion homeostasis | BCL2, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.44021 |
[BP] GO:0002009 | morphogenesis of an epithelium | BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.43579 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APEX1, CDC25B, CYP1A1, DUSP3, INSR, PRKCA | 2.42645 |
[BP] GO:0016311 | None | ALPI, ALPL, APEX1, BCL2, CDC25B, DUSP3, PTPN1, PTPRS | 2.41825 |
[BP] GO:0051480 | regulation of cytosolic calcium ion concentration | DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 | 2.40943 |
[BP] GO:0051588 | None | DRD1, DRD2, HTR1A, HTR1B, HTR2C | 2.40943 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, PTGS2, SMAD3, XDH | 2.40943 |
[BP] GO:0050433 | None | CNR1, DRD2, HTR1B, HTR2A | 2.40237 |
[BP] GO:0009410 | None | CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B | 2.39901 |
[BP] GO:0051054 | positive regulation of DNA metabolic process | AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 | 2.38462 |
[BP] GO:0008150 | biological_process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 2.37944 |
[BP] GO:0006936 | None | DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA | 2.37472 |
[BP] GO:0030815 | None | DRD2, HTR1B, HTR1E, PRKCA | 2.37373 |
[BP] GO:0010632 | regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, PTGS2, SRC, TEK | 2.36487 |
[BP] GO:0010942 | positive regulation of cell death | BCL2, CNR1, CYP1B1, F3, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH | 2.34767 |
[BP] GO:0009266 | None | ADORA1, HSPA1A, HTR1B, HTR2A, HTR2B, PTGS2 | 2.34355 |
[BP] GO:0010518 | positive regulation of phospholipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.34209 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.31376 |
[BP] GO:0002237 | response to molecule of bacterial origin | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC | 2.31227 |
[BP] GO:0030800 | None | DRD2, HTR1B, HTR1E, PRKCA | 2.31211 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC | 2.29576 |
[BP] GO:0019637 | organophosphate metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, EGFR, HSPA1A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, PTGS2, XDH | 2.29576 |
[BP] GO:0003014 | None | ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 | 2.29576 |
[BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, F3, KDR, PRKCA, PTGS2, TEK | 2.28982 |
[BP] GO:0042752 | None | ADORA1, DRD2, PPARA, RORC, TOP2A | 2.25701 |
[BP] GO:0048148 | None | DRD1, DRD2, HTR2A | 2.25597 |
[BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.25597 |
[BP] GO:0050994 | None | ADORA1, CNR1, HCAR2, PPARA | 2.25597 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | AURKB, DRD1, DRD2, EGFR, ESR1, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A | 2.25036 |
[BP] GO:0050793 | regulation of developmental process | AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESR1, F3, HTR2A, HTR2C, INSR, KDR, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TNKS2, XDH | 2.24059 |
[BP] GO:2001242 | regulation of intrinsic apoptotic signaling pathway | BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC | 2.23859 |
[BP] GO:0051094 | positive regulation of developmental process | AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, F3, HTR2A, HTR2C, INSR, KDR, PIM1, PRKCA, PTGS2, SMAD3, SRC, TEK | 2.22884 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.22884 |
[BP] GO:0006875 | cellular metal ion homeostasis | BCL2, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.22182 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, AXL, BCL2, CBR1, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ESR1, FABP4, FLT3, FUT7, GLO1, HTR2B, KDR, MET, MMP2, MMP9, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TOP2A | 2.2206 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, PRKCA, SMAD3, SRC, TEK | 2.21629 |
[BP] GO:0050776 | regulation of immune response | ALOX15, BCL2, CNR1, DRD2, DUSP3, ESR1, HSPA1A, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, PTPRS, SMAD3, SRC | 2.21092 |
[BP] GO:0033031 | positive regulation of neutrophil apoptotic process | HCAR2, PIK3CB | 2.21092 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.21092 |
[BP] GO:0038171 | None | CNR1, CNR2 | 2.21092 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.21092 |
[BP] GO:0014827 | None | HTR1D, HTR2B | 2.21092 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.21092 |
[BP] GO:0051968 | None | DRD1, EGFR, PTGS2 | 2.21092 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.21092 |
[BP] GO:0033555 | multicellular organismal response to stress | BCL2, DRD1, HTR1A, HTR2C | 2.21092 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.21092 |
[BP] GO:0007568 | aging | APEX1, AURKB, BCL2, CNR1, CYP1A1, HTR2A, PTGS2 | 2.20953 |
[BP] GO:0072593 | reactive oxygen species metabolic process | BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.20043 |
[BP] GO:0031623 | None | ACHE, DRD2, HTR1B, HTR2B | 2.184 |
[BP] GO:0032768 | None | CNR1, CNR2, EGFR, HTR2B | 2.184 |
[BP] GO:0032147 | activation of protein kinase activity | ADORA1, DRD2, EGFR, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 2.17263 |
[BP] GO:0050714 | None | ACHE, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC | 2.17032 |
[BP] GO:0007611 | None | CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, PTGS2 | 2.17032 |
[BP] GO:0051051 | negative regulation of transport | ADORA1, BCL2, CNR1, DRD2, GPR35, HSPA1A, HTR1B, HTR2A, MMP9, PTGS2 | 2.16418 |
[BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, DRD1, PRKCA, SRC, TNKS | 2.1616 |
[BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH | 2.16148 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9 | 2.16085 |
[BP] GO:0050995 | None | ADORA1, CNR1, HCAR2 | 2.16085 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HCAR2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 2.15399 |
[BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR | 2.14751 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, HSD17B2, INSR, PTGS2, SRC | 2.14179 |
[BP] GO:0097553 | None | DRD2, HTR2A, HTR2B, HTR2C | 2.13597 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.13597 |
[BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.13597 |
[BP] GO:0051128 | regulation of cellular component organization | ALOX15, AURKB, AXL, BCL2, CNR1, CSNK2A1, DRD2, EGFR, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.13219 |
[BP] GO:0006644 | phospholipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB | 2.12062 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC | 2.1117 |
[BP] GO:0051953 | None | ADORA1, CNR1, DRD2 | 2.11156 |
[BP] GO:2000209 | regulation of anoikis | BCL2, PIK3CA, SRC | 2.11156 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.11156 |
[BP] GO:0043412 | macromolecule modification | ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.09872 |
[BP] GO:0070201 | None | ACHE, BCL2, CNR1, DRD2, EGFR, HCAR2, HTR2B, MMP12, PRKCA, PTGS2, PTPN1, SMAD3, SRC | 2.09597 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TNKS, TNKS2 | 2.08825 |
[BP] GO:0010517 | regulation of phospholipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.08825 |
[BP] GO:0070988 | demethylation | APEX1, CYP1A1, CYP1A2, CYP3A4 | 2.08825 |
[BP] GO:0009968 | negative regulation of signal transduction | BCL2, DRD2, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SMAD3, SRC, XDH | 2.07761 |
[BP] GO:0030168 | platelet activation | AXL, PIK3CA, PIK3CB, PRKCA, SRC | 2.07468 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.06633 |
[BP] GO:0007202 | None | EGFR, HTR2A, HTR2B | 2.06633 |
[BP] GO:0032098 | None | HTR2C, HTR4, PPARA | 2.06633 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.06633 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.06628 |
[BP] GO:1904951 | positive regulation of establishment of protein localization | ACHE, BCL2, DRD2, EGFR, HCAR2, HTR2B, MMP12, PTGS2, SMAD3, SRC | 2.05865 |
[BP] GO:0007204 | positive regulation of cytosolic calcium ion concentration | DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C | 2.0546 |
[BP] GO:1904018 | positive regulation of vasculature development | CYP1B1, F3, KDR, PRKCA, PTGS2, TEK | 2.04976 |
[BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.0416 |
[BP] GO:0021853 | None | DRD1, DRD2 | 2.03693 |
[BP] GO:0010641 | None | F3, SRC | 2.03693 |
[BP] GO:0007598 | None | F10, F3 | 2.03693 |
[BP] GO:0071502 | None | HTR1B, HTR2B | 2.03693 |
[BP] GO:1904936 | None | DRD1, DRD2 | 2.03693 |
[BP] GO:0042321 | None | ADORA1, DRD2 | 2.03693 |
[BP] GO:0051282 | None | DRD1, DRD2, HTR2A, HTR2B, HTR2C | 2.03432 |
[BP] GO:0050708 | None | ACHE, CNR1, DRD2, EGFR, HCAR2, HTR2B, MMP12, PRKCA, SRC | 2.03081 |
[BP] GO:0050927 | None | F3, KDR, SMAD3 | 2.02484 |
[BP] GO:0060193 | positive regulation of lipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.02357 |
[BP] GO:0001775 | cell activation | ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, PRKCA, RORC, SMAD3, SRC | 2.0198 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, AXL, CA4, CNR1, CNR2, DRD1, DRD2, F10, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, TEK | 7.85209 |
[CC] GO:0005886 | plasma membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPI, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F10, F3, FLT3, GLO1, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PTPN1, PTPRS, SMAD3, SRC, TEK | 7.6351 |
[CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TYR | 7.15702 |
[CC] GO:0044459 | plasma membrane part | ABCB1, ADORA1, ADORA3, ALOX15, AXL, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTGS2, PTPRS, SRC, TEK | 6.64892 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, TEK | 6.35687 |
[CC] GO:0044425 | membrane part | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, PTPRS, SRC, TEK, TYR | 6.01215 |
[CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, EGFR, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2 | 2.64818 |
[CC] GO:0044432 | endoplasmic reticulum part | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, EGFR, F10, FLT3, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1 | 2.55899 |
[CC] GO:0031224 | None | ABCB1, ACHE, ADORA1, ADORA3, ALPI, ALPL, AXL, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPRS, TEK, TYR | 2.50305 |
[CC] GO:0098590 | plasma membrane region | ABCB1, ADORA1, CA2, CA4, CA9, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, MET, PTGS2, SRC, TEK | 2.39786 |
[CC] GO:0045121 | membrane raft | CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 2.34012 |
[CC] GO:0098857 | membrane microdomain | CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 2.3206 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2A, HTR4, HTR5A, INSR, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 2.25597 |
[CC] GO:0031233 | None | CA4, F10, F3 | 2.25597 |
[CC] GO:0044464 | cell part | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 2.19937 |
[CC] GO:0120025 | None | ADORA1, AKR1B1, CA2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TEK, TUBB3 | 2.08569 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 17.9972 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 15.9642 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, ALPI, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TNKS, TYR, XDH | 15.8678 |
[MF] GO:0004993 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8678 |
[MF] GO:0099589 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8678 |
[MF] GO:0043176 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 15.8678 |
[MF] GO:0051378 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 15.8678 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, SRC, TEK, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 13.8594 |
[MF] GO:0099528 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 13.4248 |
[MF] GO:0008227 | None | DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 13.0778 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F10, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, TNKS, TNKS2, TOP2A, TYR, XDH | 11.9593 |
[MF] GO:0070405 | ammonium ion binding | ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 11.7933 |
[MF] GO:0030594 | None | DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 11.1787 |
[MF] GO:0042165 | neurotransmitter binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 10.277 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.2053 |
[MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, EGFR, FLT3, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, SRC, TEK, TOP2A | 10.2053 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.0734 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 9.82278 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 8.64352 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 8.64352 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK | 8.64352 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK | 8.64352 |
[MF] GO:0008270 | zinc ion binding | ALPI, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PRKCA, PTPN1, RORC, SMAD3, TNKS | 8.6209 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 8.32581 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK | 8.32018 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 | 7.95161 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 | 7.51937 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.81916 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS1, PTGS2, SRC | 6.80586 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 | 6.64556 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS1, PTGS2, SRC | 6.54112 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS1, PTGS2, TYR | 6.09769 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.07969 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH | 5.99734 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, TNKS, TNKS2, TOP2A, TYR, XDH | 5.6065 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR | 5.52397 |
[MF] GO:0004930 | None | ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, GPR35, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 5.2773 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 | 5.00408 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH | 4.93874 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, INSR, PIK3CA, PIK3CB | 4.70545 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.54292 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 4.42787 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 | 4.1942 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, SRC, TEK | 4.17901 |
[MF] GO:0097159 | organic cyclic compound binding | ABCB1, ADORA1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, ESR1, FLT3, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TUBB3, XDH | 3.92669 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK | 3.92669 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.77122 |
[MF] GO:0042562 | hormone binding | ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 | 3.52428 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK | 3.50212 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 3.3633 |
[MF] GO:1901363 | heterocyclic compound binding | ABCB1, ADORA1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, FLT3, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TUBB3, XDH | 3.32361 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, APEX1, EGFR, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC | 3.27863 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.20861 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.18098 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.18098 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.1011 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.84648 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.84648 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.84648 |
[MF] GO:0071886 | None | HTR2A, HTR2C | 2.84648 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK | 2.736 |
[MF] GO:0036094 | small molecule binding | ABCB1, ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TOP2A, TUBB3, XDH | 2.73296 |
[MF] GO:0043168 | anion binding | ABCB1, ALOX15, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PTPRS, SRC, TEK, TOP2A, TUBB3, XDH | 2.67185 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, HSD11B2, HSD17B1, RORC | 2.48233 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.45564 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.45564 |
[MF] GO:0004949 | None | CNR1, CNR2 | 2.45564 |
[MF] GO:0000166 | nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TOP2A, TUBB3, XDH | 2.42855 |
[MF] GO:1901265 | nucleoside phosphate binding | ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TOP2A, TUBB3, XDH | 2.42747 |
[MF] GO:0005524 | ATP binding | ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TOP2A | 2.37574 |
[MF] GO:0003674 | molecular_function | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH | 2.37395 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC | 2.26715 |
[MF] GO:0032559 | adenyl ribonucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TOP2A | 2.25803 |
[MF] GO:0030554 | adenyl nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TEK, TOP2A | 2.22945 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.21092 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.21092 |
[MF] GO:0019902 | phosphatase binding | BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 | 2.17263 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, NQO2, XDH | 2.10469 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PRKCA, PTPN1, PTPRS, SRC, TEK | 2.09803 |
[MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.03693 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.03693 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Serotonergic synapse_Homo sapiens_hsa04726 | HTR1E, ALOX15, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, PRKCA, HTR2A, PTGS2, HTR5A, HTR4, PTGS1, HTR6, HTR7, ALOX5 | 16.9867 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 16.9867 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | HTR1E, GPR35, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, HTR5A, HTR4, HTR6, HTR7, CNR2, CNR1, ADORA3, ADORA1, DRD1, DRD2 | 13.2973 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 10.1079 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HTR1E, HTR1D, HTR1A, HTR1B, PIK3CB, HTR4, HCAR2, HTR6, PIK3CA, ADORA1, DRD1, DRD2, PPARA | 9.502 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 9.5899 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, CNR1, INSR, KDR, PRKCA, TEK, PIK3CB, DRD2, MET, EGFR, IGF1R | 8.1641 |
Gap junction_Homo sapiens_hsa04540 | SRC, TUBB3, HTR2B, HTR2C, PRKCA, HTR2A, DRD1, DRD2, EGFR | 8.1641 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, PTGS2, CYP3A4 | 8.3368 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PRKCA, PIK3CB, MMP9, MET, ESR1, EGFR, IGF1R | 7.3134 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 7.4552 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 7.4487 |
Calcium signaling pathway_Homo sapiens_hsa04020 | HTR6, HTR7, HTR2B, HTR2C, PRKCA, HTR2A, DRD1, HTR5A, HTR4, EGFR | 6.752 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, MMP2, BCL2, PIM1, PRKCA, PIK3CB, F3 | 6.5294 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, FLT3, MMP1, MMP2, PRKCA, PIK3CB, PTGS2, MMP9, EGFR, IGF1R, PIK3CA, BCL2, MET | 6.3228 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, INSR, ADORA1, PIK3CB, PTGS2, PTGS1 | 6.9485 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, EGFR, HSPA1A | 6.5701 |
Ras signaling pathway_Homo sapiens_hsa04014 | HTR7, PIK3CA, INSR, KDR, PRKCA, TEK, PIK3CB, MET, EGFR, IGF1R | 5.9329 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, INSR, BCL2, PRKCA, TEK, PIK3CB, EGFR, IGF1R | 6.4885 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | ABCB1, PIK3CA, BCL2, PIM1, CYP1B1, PRKCA, PTGS2, MMP9, MET, EGFR, CDC25B | 5.8371 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, HTR2B, HTR2C, PRKCA, PIK3CB, HTR2A | 5.4556 |
Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, BCL2, PRKCA, PIK3CB, MET, EGFR, IGF1R | 5.4127 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, ALOX15, AKR1B1, PTGS2, TYR, CYP3A4, CYP19A1, PTGS1, HSD11B1, CYP2A6, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, ALPI, XDH | 5.102 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PRKCA, PIK3CB, PTGS2 | 5.4556 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | PIK3CA, INSR, KDR, BCL2, PRKCA, TEK, PIK3CB, MET, EGFR, IGF1R | 4.497 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, PIK3CA, SRC, BCL2, PRKCA, PIK3CB, MMP9 | 4.4283 |
Glioma_Homo sapiens_hsa05214 | PIK3CA, PRKCA, PIK3CB, EGFR, IGF1R | 4.1056 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, INSR, PIK3CB, IGF1R, HSPA1A | 4.125 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, BCL2, ADORA1, PRKCA, PIK3CB | 3.9367 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, PIK3CA, INSR, PIK3CB, EGFR, IGF1R | 3.697 |
Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, EGFR, IGF1R | 3.9442 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PRKCA, PIK3CB, PTGS2, EGFR | 3.3161 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, PTGS2, PTGS1 | 4.1787 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET, EGFR | 4.0543 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, PIK3CA, INSR, PRKCA, PIK3CB | 5.1129 |
Prostate cancer_Homo sapiens_hsa05215 | PIK3CA, BCL2, PIK3CB, EGFR, IGF1R | 3.5181 |
ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PRKCA, PIK3CB, EGFR | 3.5538 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.0351 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, BCL2, PRKCA, PIK3CB | 3.1178 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.0417 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, INSR, PIK3CB, PPARA | 3.1445 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PRKCA, PIK3CB, ESR1 | 3.0417 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, BCL2, PIK3CB, HSPA1A | 3.0417 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PRKCA, PIK3CB, MMP9 | 3.0417 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | PIK3CA, PRKCA, PIK3CB, EGFR | 3.197 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | PIK3CA, INSR, PRKCA, PIK3CB, EGFR | 2.7038 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.1777 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, PIK3CA, BCL2, PIK3CB | 3.0664 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, INSR, ADORA1, PIK3CB | 2.4605 |
Taste transduction_Homo sapiens_hsa04742 | HTR1E, HTR1D, HTR1A, HTR1B | 2.6863 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1 | 2.8972 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, PRKCA, EGFR | 2.5589 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, PIK3CA, PIK3CB, EGFR | 3.0169 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PIK3CB, CDC25B, IGF1R | 2.4605 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, BCL2, PIK3CB, HSPA1A | 2.1582 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, INSR, PIK3CB, IGF1R | 2.5136 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PRKCA, PIK3CB, EGFR | 2.4259 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.3029 |
Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, BCL2, PIK3CB, PTGS2 | 2.636 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 2.7726 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.1586 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, CYP3A4 | 3.0337 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 2.9512 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, INSR, PIK3CB, IGF1R | 2.1488 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 2.0258 |
Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA, EGFR | 2.0485 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, INSR, PIK3CB | 2.0147 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, PIK3CA, PIK3CB, IGF1R | 1.9927 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, PRKCA, EGFR, CDC25B, HSPA1A | 1.8271 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, INSR, PIK3CB, PPARA | 1.9197 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, BCL2, PRKCA, PIK3CB | 1.9454 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, BCL2, PIM1, PIK3CB | 1.8564 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2311 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2424 |
Influenza A_Homo sapiens_hsa05164 | PIK3CA, PRKCA, PIK3CB, HSPA1A | 1.7251 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.2782 |
Phagosome_Homo sapiens_hsa04145 | TUBB3 | 0.2782 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.3153 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.7005 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3296 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3372 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB, EGFR | 1.477 |
Vascular smooth muscle contraction_Homo sapiens_hsa04270 | PRKCA | 0.3426 |
Glutamatergic synapse_Homo sapiens_hsa04724 | PRKCA | 0.3566 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.3944 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2, HSPA1A | 0.6297 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.6012 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.2348 |
Alcoholism_Homo sapiens_hsa05034 | DRD1, DRD2 | 0.6012 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3, PIK3CA, PIK3CB | 0.7823 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4127 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.7284 |
Circadian entrainment_Homo sapiens_hsa04713 | PRKCA | 0.4127 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, BCL2, PIK3CB | 1.33 |
Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 0.9767 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PRKCA, PIK3CB | 1.3583 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC, PRKCA | 1.334 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.43 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1, PRKCA | 1.3183 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, BCL2, PIK3CB | 1.4744 |
Salivary secretion_Homo sapiens_hsa04970 | PRKCA | 0.43 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.7665 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PRKCA, PIK3CB | 1.7251 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 0.7972 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, PRKCA, DRD1 | 1.7366 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.4396 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB | 1.0605 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.43 |
Dopaminergic synapse_Homo sapiens_hsa04728 | PRKCA, DRD1, DRD2 | 1.4052 |
Insulin secretion_Homo sapiens_hsa04911 | PRKCA | 0.4381 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4411 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PRKCA, PIK3CB | 1.6584 |
Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | PRKCA | 0.447 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PRKCA, PIK3CB | 2.0241 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3, PIK3CA, PIK3CB | 1.6262 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PRKCA, PIK3CB | 1.6776 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | CNR1, PRKCA, PTGS2 | 1.6513 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 0.9041 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3, PIK3CA, PIK3CB | 1.965 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 1.7251 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 0.9147 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 2.0434 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.4623 |
Melanogenesis_Homo sapiens_hsa04916 | PRKCA, TYR | 0.9404 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.4789 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.4885 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PRKCA, PIK3CB | 2.1488 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2, PRKCA | 0.9674 |
Thyroid hormone synthesis_Homo sapiens_hsa04918 | PRKCA | 0.4862 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.0241 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 1.0087 |
Long-term potentiation_Homo sapiens_hsa04720 | PRKCA | 0.5074 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2, CYP3A4 | 1.9927 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC, PRKCA | 1.0221 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5102 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2, CYP3A4 | 2.0147 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.513 |
Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB, EGFR | 2.2977 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.1513 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10, F3 | 1.0974 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2, PRKCA | 1.1444 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.5672 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.1692 |
Amphetamine addiction_Homo sapiens_hsa05031 | PRKCA, DRD1 | 1.2109 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, INSR, PIK3CB | 2.3829 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.5931 |
Vibrio cholerae infection_Homo sapiens_hsa05110 | PRKCA | 0.5931 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6012 |
Long-term depression_Homo sapiens_hsa04730 | PRKCA, IGF1R | 1.2868 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.231 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, CYP3A4, XDH | 2.4259 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.2963 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.6323 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 2.5646 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | TUBB3, PRKCA | 1.3366 |
Cocaine addiction_Homo sapiens_hsa05030 | DRD1, DRD2 | 1.4176 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6668 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7167 |
African trypanosomiasis_Homo sapiens_hsa05143 | PRKCA | 0.7167 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | PRKCA, ESR1 | 1.4473 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.4744 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4 | 2.9329 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7496 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.7924 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.7167 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.7284 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.7518 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7978 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.7595 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7924 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7215 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6457 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9523 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL, ALPI | 2.2977 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 5.1238 |